A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases

The purpose of this study is to evaluate the safety, tolerability, PK, and PD following subcutaneous injections of YH35324 in atopic healthy subjects or adult subjects with mild allergic diseases. Eli...

Lead sponsor: Yuhan Corporation•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1

A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases

NCT05564221 · Atopic Healthy Subjects, Adult Subjects With Allergic Diseases

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 3, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment68

Start dateSep 2021

Last updatedDec 3, 2024

Condition

Atopic Healthy Subjects Adult Subjects with Mild Allergic Diseases

Locations shown

Ajou University Hospital

Suwon, Gyeonggi-do

Asan Medical Center

Pungnap-tong, Seoul

Severance Hospital, Yonsei University Health System

Sinchon-dong, Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 3, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions